Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
JCV serology in time: 3 years of follow-up.
IL4I1 augments CNS remyelination and axonal protection by modulating T cell driven inflammation.
Peripheral Vasculitis, Intermediate Uveitis and Interferon Use in Multiple Sclerosis.
Peripheral and central neuronal ATF3 precedes CD4+ T-cell infiltration in EAE.
Aquaporin-4 IgG autoimmune syndrome and immunoreactivity associated with thyroid cancer.
Epigenetic Modifications and Therapy in Multiple Sclerosis.
Haemopoietic stem-cell transplantation for multiple sclerosis: what next?
Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO).
Mast cells: New therapeutic target in helminth immune modulation.
Familial amyotrophic lateral sclerosis with an I104F mutation in the SOD1 gene: Multisystem degeneration with neurofilamentous aggregates and SOD1 inclusions.
[Acute disseminated encephalomyelitis presenting as an acute urinary febrile retention].
Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disorders.
Longitudinal diffusion tensor imaging of the rat brain after hexachlorophene exposure.
Progesterone treatment modulates mRNA OF neurosteroidogenic enzymes in a murine model of multiple sclerosis.
Modeling the Chronic Loss of Optic Nerve Axons and the Effects on the Retinal Nerve Fiber Layer Structure in Primary Disorder of Myelin.
RAR-related orphan receptor A (RORA): A new susceptibility gene for multiple sclerosis.
The neuroinflammatory component of gray matter pathology in multiple sclerosis.
Changes in the Expression of miR-34a and its Target Genes Following Spinal Cord Injury In Rats.
Deficits in medio-lateral balance control and the implications for falls in individuals with multiple sclerosis.
[Effect of axonal developmental disorders in the corpus callosum on the neurological function after birth in septic neonatal rats].
Neurogenic bowel dysfunction (NBD) translation and linguistic validation to classical Arabic.
The effect of tacrolimus on facial nerve injury: Histopathological findings in a rabbit model.
Lithium Restores Age Related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome.
Repeated mild traumatic brain injury: potential mechanisms of damage.
Tuning PAK Activity to Rescue Abnormal Myelin Permeability in HNPP.
Pages
« first
‹ previous
…
817
818
819
820
821
822
823
824
825
…
next ›
last »